Fitterfly HealthTech Pvt Ltd Logo
< Back to Listing
Conference abstracts Conference abstracts
Real-world effectiveness of Diabefly digital therapeutics program for glycemic control during COVID-19 pandemic in India
Dec 2021 | Poster | By Dr Ritika Verma, Ruchira Ranadive, Sanjay Kalra, Dr.Tejal Lathia , Mohan Shenoy, Akshata Agnihotri, Om Lakhani, Vandana Jain, Mitali Joshi, Rabindra Das, Ashish Sarawte, Dr Arbinder Kumar Singal

Real-world effectiveness of Diabefly digital therapeutics program for glycemic control during COVID-19 pandemic in India

Lockdown due to the COVID-19 pandemic had led to the disruptions in the management of diabetes. This study has 72 participants and has examined the effectiveness of the Diabefly program on people with type 2 diabetes (T2D). An effective reduction in HbA1c,weight and BMI by 1.96%, 2.62kg, and 0.88 kg/m2 was observed respectively. Group with higher than median interactions showed remarkably higher reduction in HbA1c. Thus, Diabefly program proved to be an effective tool for diabetes self-management, education, support, and continuity-of-care during the COVID-19 pandemic.

Read full paper